Bullish ChartThe chart coincides with the internal developments. Can't for the time when the announcement comes that they have partnered up with a major. Multiple interested parties bodes well for the share price and confidence that we have a legitimate drug compound with little or no toxicity. Toxicity is a major factor in any cancer drug going forward.